ALSP Orchid Acquisition Corp. I announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ALORU” Friday, November 19.
The new SPAC intends to target life science companies in North America and Singapore with a particular emphasis on companies developing assets and next-generation platform technologies with broad applicability. ALSP Orchid I is led by Chief Executive Officer and President Thong Q. Le, Chief Financial Officer Ian A. W. Howes, Chief Development Officer Kendall M. Moher Ph.D., Chief Operating Officer Andras T. Forgacs, Chief Business Officer Kevin T. Chow Ph.D., Chairman Nominee of the Board of Directors Bruce L.A. Carter, Ph.D., and Senior Advisers Randall C. Schatzman, Ph.D., and Philip Yeo Liat Kok.
Total SPAC deal count for 2021 year-to-date is now 551. This offering is expected to close on Tuesday, November 23.
Stifel, Nicolaus & Company, Incorporated and Nomura Securities International, Inc. are acting as the joint book-running managers for the offering. Cooley LLP is serving as Issuer’s Counsel with Glovsky and Popeo, P.C. serving as Underwriter’s Counsel. Grant Thornton LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...